In recent trading, shares of Kestra Medical Technologies Ltd (Symbol: KMTS) have crossed above the average analyst 12-month target price of $28.62, changing hands for $29.37/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: d
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.